A quantitative evaluation of the relationships between growth hormone secretion and delta wave electroencephalographic activity during normal sleep and after enrichment in delta waves

Sleep

Volumn 19, Issue 10, 1996, Pages 817-824

  Gronfier, C ^a   Luthringer, R ^b   Follenius, M ^a   Schaltenbrand, N ^b   Macher, J P ^b   Muzet, A ^a   Brandenberger, G ^a  

^a CNRS   (France)

^b FORENAP   (France)

Author keywords

Delta wave activity; EEG spectral analysis; Growth hormone secretion; Sleep

Indexed keywords

GROWTH HORMONE; PLACEBO; RITANSERIN; SEROTONIN 2 ANTAGONIST;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DELTA RHYTHM; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; ELECTROENCEPHALOGRAM; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE RELEASE; HUMAN; HUMAN EXPERIMENT; MALE; NIGHT SLEEP; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; POLYSOMNOGRAPHY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SLEEP; SLOW WAVE SLEEP;

EID: 0030433148     PISSN: 01618105     EISSN: None     Source Type: Journal    
DOI: 10.1093/sleep/19.10.817     Document Type: Article

References (40)

1. Takahashi Y, Kipnis DM, Daughaday WH. Growth hormone secretion during sleep. J Clin Invest 1969;47:2079-90.
2. Sassin JF, Parker DC, Mace JW, Gotlin RW, Johnson LC, Rossman LG. Human growth hormone release: relation to slow-wave sleep and sleep-waking cycles. Science 1969;165:513-5.
3. Jarret DB, Coble P, Kupfer DJ, Greenhouse JB. Sleep-related hormone secretion in depressed patients. Acta Psychiatr Belg 1985;85:603-14.
4. Steiger A, Herth T, Holsboer F. Sleep-electroencephalography and the secretion of cortisol and growth hormone in normal controls. Acta Endocrinol (Copenh) 1987;116:36-42.
5. Van Cauter E, Turek FW. Endocrine and other biological rhythms. In: Degroot LJ, ed. Endocrinology. Philadelphia: WB Saunders, 1994:2487-548.
6. Holl RW, Hartman ML, Veldhuis JD, Taylor WM, Thorner MO. Thirty-second sampling of plasma growth hormone in man: correlation with sleep stages. J Clin Endocrinol Metab 1991;72:854-61.
7. Van Cauter E, Kerkhofs M, Caufriez A, Van Onderbergen A, Thorner MO, Copinschi G. A quantitative estimation of growth hormone secretion in normal man: reproducibility and relation to sleep and time of day. J Clin Endocrinol Metab 1992;74:1441-50.
8. Aeschbach D, Borbely AA. All-night dynamics of the human sleep EEG. J Sleep Res 1993;2:70-81.
9. Borbely AA, Baumann F, Brandeis D, Strauch I, Lehmann D. Sleep deprivation: effect on sleep stages and EEG power density in man. Electroencephalogr Clin Neurophysiol 1981;51:483-93.
10. Jarret DB, Greenhouse JB, Miewald JM, Fedorka IB, Kupfer DJ. A reexamination of the relationship between growth hormone secretion and slow wave sleep using delta wave analysis. Biol Psychiatry 1990;27:497-509.
11. Sharpley AL, Solomon RA, Fernando AI, Da Roza Davis JM, Cowen PJ. Dose-related effects of selective 5HT2 receptor antagonists on slow wave sleep in humans. Psychopharmacology 1990;10:568-9.
12. Idzikowski C. The effects of ritanserin and seganserin on human slow wave sleep. In: Wauquier A, Dugovic C, Radulovacki M, eds. Slow wave sleep: physiological, pathophysiological and functional aspects. New York: Raven Press, 1989:197-215.
13. Dugovic C. Functional activity of 5-HT2 receptors in the modulation of the sleep/wakefulness states. J Sleep Res 1992;1:163-8.
14. Rechtschaffen A, Kales A, eds. A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects. Washington, DC: US Government Printing Office, 1968.
15. Cooley JW, Tuckey JW. An algorithm for the machine calculation of complex Fourier series. Math Comp 1965;19:297-301.
16. Faria ACS, Veldhuis J, Thorner MO, Lee Vance M. Half-time of endogenous growth hormone (GH) disappearance in normal man after stimulation of GH secretion by GH-releasing hormone and suppression with somatostatin. J Clin Endocrinol Metab 1989;68:535-41.
17. Refetoff S, Sonksen PH. Disappearance rate of endogenous and exogenous human growth hormone in man. J Clin Endocrinol Metab 1970;30:386.
18. Edwards AL, ed. Experimental design in psychological research. New York: Rinehart and Co Inc, 1957.
19. Snedecor G, Cochran W, eds. Statistical methods. Ames: Iowa State University Press, 1980.
20. Van Cauter E. Quantitative methods for the analysis of circadian and episodic hormone fluctuations. In: Van Cauter E, Copinschi G, eds. Human pituitary hormones: circadian and episodic variations. The Hague: Nijhoff M, 1981:1-25.
21. Veldhuis JD, Johnson ML, Seneta E. Analysis of the copulsatility of anterior pituitary hormones. J Clin Endocrinol Metab 1991;73:569-76.
22. Leach C. Nonparametric methods for complex data sets. In: Lovie P, Lovie AD, eds. New developments in statistics for psychology and the social sciences, Vol. 2. London, New York: BPS Books, 1991:1-18.
23. Rubin RT, Grouin PR, Arenander AT, Poland RE. Human growth hormone release during sleep following prolonged flurazepam administration. Res Commun Chem Pathol Pharmacol 1973;6:331-4.
24. Mendelson WB. Studies of human growth hormone secretion in sleep and waking. Int Rev Neurobiol 1982;23:367-89.
25. McCracken JT, Poland RE, Rubin RT, Tondo L. Dose-dependent effects of scopolamine on nocturnal growth hormone secretion in normal adult men: relation to delta-sleep changes. J Clin Endocrinol Metab 1990;72:90-5.
26. Steiger A, Guldner J, Hemmeter U, Rothe B, Wiedemann K, Holsboer F. Effects of growth hormone-releasing hormone and somatostatin on sleep EEG and nocturnal hormone secretion in male controls. Neuroendocrinology 1992;56:566-73.
27. Kerkhofs M, Van Cauter E, Van Onderbergen A, Caufriez A, Thorner MO, Copinschi G. Sleep-promoting effects of growth hormone-releasing hormone in normal men. Am J Physiol 1993;264:E594-8.
28. Kupfer DJ, Jarret DB, Elhers CL. The effect of GRF on the EEG sleep of normal males. Sleep 1991;14:87-8.
29. Obal FJR, Payne L, Kapas L, Opp M, Krueger JM. Inhibition of growth hormone-releasing factor suppresses both sleep and growth hormone secretion in the rat. Brain Res 1991;557:149-53.
30. Holsboer F, Von Bardeleben U, Steiger A. Effects of intravenous corticotropin-releasing hormone upon sleep-related growth hormone surge and sleep EEG in man. Neuroendocrinology 1988;48:32-8.
31. Hartman ML, Iranmanesh A, Thorner MO, Veldhuis JD. Evaluation of pulsatile patterns of growth hormone release in humans: a brief review. Am J Hum Biol 1993;5:603-14.
32. Thorner MO, Vance ML, Hartman ML, Holl RW, Evans WS, Veldhuis JD, Van Cauter E, Copinschi G, Bowers CY. Physiological role of somatostatin on growth hormone regulation in humans. Metabolism 1990;39(Suppl 2):40-2.
33. Van Cauter E, Caufriez A, Kerkhofs M, Van Onderbergen A, Thorner MO, Copinschi G. Sleep, awakenings, and insulin-like growth factor-I modulate the growth hormone (GH) secretory response to GH-releasing hormone. J Clin Endocrinol Metab 1992;74:1451-9.
34. Clarenbach P, Birmanns B, Jaursch-Hancke C. The effect of ritanserin on sleep and hormones in man. In: Koella WP, Obal F, Schulz H, Visser P, eds. Sleep '86. Stuttgart, New York: Gustav Fischer Verlag, 1988:355-8.
35. Tepavcevic D, Giljevic Z, Korsic M, Halimi S, Suchanek E, Jelic T, Aganovic I, Kozic B, Plavsic V. Effects of ritanserin, a novel serotonin-S2 receptor antagonist, on the secretion of pituitary hormones in normal humans. J Endocrinol Invest 1994;17:1-5.
36. Rocco A, Pastore R, Nardone MR, D'Urso R, Naddeo G, Martocchia A, Baldelli R, Falaschi P. Lack of effect of ritanserin, a specific 5HT2 antagonist, on basal pituitary hormone secretion in normal subjects. Neuroendocrinol Lett 1995;17:51-6.
37. Dugovic C, Wauquier A, Leysen JE, Janssen PAJ. Role of serotonin-S2 receptors in the control of sleep-wakefulness states in the rat. In: Wauquier A, Dugovic C, Radulovacki M, eds. Slow wave sleep: physiological, pathophysiological and functional aspects. New York: Raven Press, 1989:183-96.
38. Sommerfelt L, Ursin R. The 5-HT2 antagonist ritanserin decreases sleep in cats. Sleep 1993;16:15-22.
39. Borbely AA, Trachsel L, Tobler I. Effect of ritanserin on sleep stages and sleep EEG in rat. Eur J Pharmacol 1988;156:275-8.
40. Dijk DJ, Beersma DGM, Daan S, van den Hoofdakker RH. Effects of seganserin, a 5-HT2 antagonist, and temazepam on human sleep stages and EEG power spectra. Eur J Pharmacol 1989;171:207-18.